Salvatore Leotta

1.2k total citations
59 papers, 593 citations indexed

About

Salvatore Leotta is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Salvatore Leotta has authored 59 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 16 papers in Oncology and 11 papers in Genetics. Recurrent topics in Salvatore Leotta's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Salvatore Leotta is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (10 papers). Salvatore Leotta collaborates with scholars based in Italy, Denmark and Argentina. Salvatore Leotta's co-authors include Giuseppe Milone, Alessandra Cupri, Francesco Di Raimondo, Andrea Spadaro, Rosario Giustolisi, Ernesto Amato, Giuseppe A. Palumbo, Andrea Duminuco, Stefano Pergolizzi and A. Italiano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Salvatore Leotta

55 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Leotta Italy 13 279 141 96 92 81 59 593
Naeem Chaudhri Saudi Arabia 14 358 1.3× 237 1.7× 72 0.8× 82 0.9× 55 0.7× 59 816
Alaa Elhaddad Egypt 15 233 0.8× 142 1.0× 99 1.0× 95 1.0× 47 0.6× 65 518
Orhan Ayyıldız Türkiye 16 324 1.2× 72 0.5× 179 1.9× 93 1.0× 40 0.5× 64 657
Frank G. Keller United States 10 208 0.7× 66 0.5× 74 0.8× 50 0.5× 42 0.5× 26 425
Charalampia Kyriakou United Kingdom 12 334 1.2× 334 2.4× 113 1.2× 120 1.3× 33 0.4× 29 729
Jón Kristinsson Netherlands 14 304 1.1× 98 0.7× 53 0.6× 157 1.7× 78 1.0× 23 905
E Pozzoli Italy 13 248 0.9× 113 0.8× 104 1.1× 97 1.1× 53 0.7× 43 585
Maurizio Brunetti Italy 11 373 1.3× 180 1.3× 152 1.6× 71 0.8× 28 0.3× 16 604
Hazzaa Alzahrani Saudi Arabia 11 193 0.7× 68 0.5× 62 0.6× 40 0.4× 33 0.4× 57 416
Philip A. Stevenson United States 14 298 1.1× 199 1.4× 87 0.9× 63 0.7× 27 0.3× 45 733

Countries citing papers authored by Salvatore Leotta

Since Specialization
Citations

This map shows the geographic impact of Salvatore Leotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Leotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Leotta more than expected).

Fields of papers citing papers by Salvatore Leotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Leotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Leotta. The network helps show where Salvatore Leotta may publish in the future.

Co-authorship network of co-authors of Salvatore Leotta

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Leotta. A scholar is included among the top collaborators of Salvatore Leotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Leotta. Salvatore Leotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stagno, Fabio, Stefania Stella, Salvatore Leotta, et al.. (2025). No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level. International Journal of Molecular Sciences. 26(5). 1840–1840.
2.
Duminuco, Andrea, Salvatore Leotta, Elisa Mauro, et al.. (2025). Real-World Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric Cohort. Journal of Clinical Medicine. 14(14). 5110–5110. 1 indexed citations
3.
Gozzo, Lucia, Salvatore Leotta, Giovanni Luca Romano, et al.. (2024). Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease. Journal of Clinical Medicine. 13(14). 4273–4273. 2 indexed citations
4.
Duminuco, Andrea, Alessandra Cupri, Nunziatina Laura Parrinello, et al.. (2023). Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients. Journal of Clinical Medicine. 12(2). 578–578. 10 indexed citations
5.
Fabro, Vittorio Del, Nunziatina Laura Parrinello, Alessandro Allegra, et al.. (2023). Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. 30(11). 9710–9733. 8 indexed citations
6.
Duminuco, Andrea, Giuliana Giunta, Concetta Conticello, et al.. (2023). Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions. Cancer. 130(1). 41–50. 13 indexed citations
7.
Duminuco, Andrea, et al.. (2023). Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study. Journal of Clinical Medicine. 12(2). 520–520. 4 indexed citations
8.
Romano, Alessandra, Claudio Cerchione, Concetta Conticello, et al.. (2022). Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection. Cancers. 14(5). 1173–1173. 3 indexed citations
9.
Leotta, Salvatore, et al.. (2022). Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives. Journal of Clinical Medicine. 11(1). 253–253. 29 indexed citations
10.
Milone, Giuseppe, Giuseppe Milone, Maria Grazia Scuderi, et al.. (2021). Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortality. Experimental Hematology. 95. 58–67.e4.
11.
Markovic, Uroš, Alessandra Romano, Vittorio Del Fabro, et al.. (2021). Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey. Frontiers in Oncology. 11. 624405–624405. 7 indexed citations
12.
Matteo, Cristina, Salvatore Leotta, Nunziatina Laura Parrinello, et al.. (2021). Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement. Cancer Chemotherapy and Pharmacology. 89(2). 267–270. 10 indexed citations
13.
Milone, Giuseppe, Concetta Conticello, Salvatore Leotta, et al.. (2020). Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost. Leukemia Research Reports. 14. 100227–100227. 4 indexed citations
14.
Leotta, Salvatore, Giuseppe Sapienza, Uroš Markovic, et al.. (2020). Preliminary Results of a Combined Score Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic Transplantation. Frontiers in Immunology. 10. 3158–3158. 7 indexed citations
15.
Brønden, Andreas, et al.. (2019). Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide. Gastroenterology. 157(2). 569–571. 19 indexed citations
16.
Leotta, Salvatore, Ernesto Amato, Nicola Settineri, et al.. (2018). Patient dose in image guided radiotherapy: Monte Carlo study of the CBCT dose contribution. SHILAP Revista de lepidopterología. 2 indexed citations
17.
18.
Milone, Giuseppe, Massimo Martino, Salvatore Leotta, et al.. (2017). Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma. Leukemia & lymphoma. 59(1). 42–48. 11 indexed citations
19.
Amato, Ernesto, A. Italiano, Salvatore Leotta, Stefano Pergolizzi, & L. Torrisi. (2013). Monte Carlo study of the dose enhancement effect of gold nanoparticles during X-ray therapies and evaluation of the anti-angiogenic effect on tumour capillary vessels. Journal of X-Ray Science and Technology. 21(2). 237–247. 24 indexed citations
20.
Ďuricová, Dana, Natalia Pedersen, Johan Burisch, et al.. (2011). Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab. Gastroenterology. 140(5). S–203. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naeem Chaudhri Breakdown of academic impact, for papers by Alaa Elhaddad Breakdown of academic impact, for papers by Orhan Ayyıldız Breakdown of academic impact, for papers by Frank G. Keller Breakdown of academic impact, for papers by Charalampia Kyriakou Breakdown of academic impact, for papers by Jón Kristinsson Breakdown of academic impact, for papers by E Pozzoli Breakdown of academic impact, for papers by Maurizio Brunetti Breakdown of academic impact, for papers by Hazzaa Alzahrani Breakdown of academic impact, for papers by Philip A. Stevenson
Rankless by CCL
2026